Évaluation du risque pour la santé cardiovasculaire
Revu par Dr Krishna Vakharia, MRCGPDernière mise à jour par Dr Colin Tidy, MRCGPLast updated 13 juin 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
- Add to preferred sources on Google
Dans cette série :Maladie cardiovasculairerégime méditerranéen
A cardiovascular health risk assessment provides an accurate estimate of your risk of developing cardiovascular disease (eg, angina, heart attack, stroke or peripheral arterial disease) over the following 10 years, and provides an opportunity for you to make any changes that will reduce this risk.
If you already have a cardiovascular disease or diabetes then your risk does not need to be assessed because you are already in the high-risk group.
Dans cet article:
Video picks for Maladies cardiaques
Continuez à lire ci-dessous
Why is a cardiovascular risk assessment important?
Cardiovascular disease (CVD) accounts for almost a quarter of all deaths in the UK. Risk factors that increase the risk of developing CVD include:
Risk factors that cannot be changed: age, being male, having a family history of CVD, and ethnic background (eg, people of South Asian origin have an increased risk).
Risk factors that can be changed: smoking, high cholesterol, lack of physical activity, unhealthy diet, alcohol intake above recommended levels, being overweight.
Conditions that increase the risk of CVD include hypertension, diabète sucré, la maladie rénale chronique, high lipids, polyarthrite rhumatoïde, grippe, serious mental health problems, and periodontitis (gum disease).
By having a cardiovascular risk assessment, you can get an accurate estimate of your risk of developing CVD over the following 10 years and ways that you can reduce this risk.
What is a cardiovascular health risk assessment?
Retour au sommaireA cardiovascular risk assessment is an assessment of a person's risk of cardiovascular disease (CVD), such as the risk of developing heart disease or a stroke, and provides an assessment of the degree of risk.
The assessment provides an estimate of your risk of developing CVD over the following 10 years.
Within the Health Check Programme in England, everyone aged 40-74 years, not already diagnosed with cardiovascular disease (CVD), diabète, or la maladie rénale chronique, is invited every five years for a free health check, which includes and assessment of:
CVD risk.
Démence (in those aged 65-74 years).
The Health Check also includes screening for diabetes mellitus and chronic kidney disease if you are at increased risk.
Continuez à lire ci-dessous
Who should have a cardiovascular health risk assessment?
Retour au sommaireAll adults aged 40 or more should have a CVD risk assessment every five years apart from those who people who are already known to be at high risk of CVD, which includes anyone:
Already known to have CVD.
Aged 85 years or over (are assumed to be at high risk because of age alone, if a smoker or with high blood pressure.
Who is a person with familial hypercholesterolaemia, or other inherited disorders of lipid metabolism.
People with type 1 diabetes mellitus ou la maladie rénale chronique stages 3, 4, or 5 are at high risk, and so a CVD risk assessment is not needed, but an assessment may help to make an informed choice on whether to take a medicine to reduce cholesterol (statin).
What does a cardiovascular health risk assessment involve?
Retour au sommaireA doctor or nurse will ask if you have any current lifestyle risk factors that increase your risk of developing a cardiovascular disease. These include smoking, l'obésité, a poor diet, lack of activité physique and drinking a lot of alcohol.
You will then have a blood test to check your blood cholesterol and sugar (glucose) level. Your blood pressure will be measured.
A score is calculated based on several of these risk factors, your age and sex. An adjustment to the score is made for certain other risk factors such as strong family history and ethnic origin.
There are many different calculators. The QRISK®3 risk assessmentis used in England and Wales. This provides an estimate that is accurate for most people but may underestimate the CVD risk for some people if:
They have received treatment for VIH.
They are taking medicines that can cause high lipids (eg, immunosuppressants).
They have high blood levels of triglycerides (above 4.5 mmol/L).
They are already taking medicines to lower blood pressure or to lower cholesterol.
They have recently given up smoking.
The assessment should be repeated every five years, but may be advised earlier if there are any changes that may affect your CVD risk.
Continuez à lire ci-dessous
What does the assessment score mean?
Retour au sommaireYou are given a score as a percentage (%) chance. So, for example, if your score is 30% this means that you have a 30% chance of developing a cardiovascular disease within the following 10 years. This is the same as saying you have a 30 in 100 chance (or a 3 in 10 chance).
So in this example, 3 in 10 people with the same risk factors that you have will develop a cardiovascular disease within the following 10 years.
Who should be treated to reduce their cardiovascular health risk?
Retour au sommaireEveryone, including those at low risk of CVD, should follow lifestyle advice to help reduce CVD risk and stay healthy. The lifestyle advice includes:
Treatment with a medicine called a statin to reduce cholesterol is usually advised if you have an estimated 10-year CVD risk of 10% or more and if lifestyle interventions have not been effective. See also the leaflets on Statins and other Lipid-lowering Medicines et High Cholesterol.
What if I am at low risk?
Retour au sommaireIf you are at low risk, it does not mean you have no risk - just a lesser risk. Medication is not usually prescribed. However, you may be able to reduce whatever risk you do have even further by any relevant changes in your lifestyle (as described above).
Some people with a low risk buy a low-dose statin drug from a pharmacy to lower their cholesterol level. Statin medicines are available on prescription but only funded by the NHS if your risk is 10% or more.
If you do buy a statin and take it regularly, it is best to discuss this with a healthcare professional so that you can be advised about the risks and benefits of taking a statin.
Patient picks for Maladies cardiaques

Santé cardiaque et vaisseaux sanguins
Angine de poitrine
L'angine de poitrine est une douleur provenant du cœur. Elle est généralement causée par un rétrécissement des vaisseaux sanguins du cœur - les artères (coronaires). Le traitement habituel comprend un médicament statine pour réduire votre taux de cholestérol, de l'aspirine à faible dose pour aider à prévenir une crise cardiaque, et un bêta-bloquant pour protéger le cœur et prévenir les douleurs d'angine. Un médicament inhibiteur de l'enzyme de conversion de l'angiotensine (ACE) est conseillé dans certains cas. Parfois, une angioplastie ou une chirurgie sont des options pour élargir ou contourner les artères rétrécies.
by Dr Hayley Willacy, FRCGP

Santé cardiaque et vaisseaux sanguins
Maladie des valves cardiaques
Les valves cardiaques se trouvent entre les cavités du cœur et régulent le flux sanguin à travers le cœur. Il existe quatre types courants de problèmes de valves cardiaques : la sténose mitrale, l'insuffisance mitrale, la sténose aortique et l'insuffisance aortique. La fiche intitulée Anatomie du cœur comprend des détails sur la fonction du cœur et la façon dont il bat.
par Dr Philippa Vincent, MRCGP
Lectures complémentaires et références
- Risk estimation and the prevention of cardiovascular disease; Scottish Intercollegiate Guidelines Network - SIGN (2017)
- Recommandations européennes 2021 sur la prévention des maladies cardiovasculaires en pratique clinique; Société Européenne de Cardiologie (2021)
- CVD risk assessment and management; NICE CKS, May 2023 (UK access only)
- QRISK®3 calculator.
- NHS Health Checks: applying All Our Health; GOV.UK. Updated March 2022.
- Cardiovascular risk assessment and lipid modification; NICE Quality standard, May 2023
- Maladie cardiovasculaire : évaluation et réduction des risques, y compris la modification des lipides; Ligne directrice clinique NICE (juillet 2014 - dernière mise à jour mai 2023) Remplacée par NG238
Continuez à lire ci-dessous
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
Next review due: 11 Jun 2028
13 juin 2023 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Vous ne vous sentez pas bien ?
Évaluez vos symptômes en ligne gratuitement
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
By subscribing you accept our Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.